We are live on ! Find out more
Two Sigma Advisers

Two Sigma Advisers Portfolio holdings

AUM $51.4B
1-Year Est. Return 31.07%
This Fund
S&P 500
This Quarter Est. Return
-16.56%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$35.3B
AUM Growth
-$2.37B
Cap. Flow
+$5.08B
Cap. Flow %
14.42%
Top 10 Hldgs %
12.79%
Holding
3,021
New
306
Increased
1,176
Reduced
1,104
Closed
398

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$410M
2
SNAP icon
Snap
SNAP
+$321M
3
MO icon
Altria Group
MO
+$312M
4
META icon
Meta Platforms (Facebook)
META
+$295M
5
INTC icon
Intel
INTC
+$283M

Top Sells

Rank Stock Value
1
CERN
Cerner Corp
CERN
+$407M
2
ABBV icon
AbbVie
ABBV
+$283M
3
SPGI icon
S&P Global
SPGI
+$251M
4
AMZN icon
Amazon
AMZN
+$221M
5
LLY icon
Eli Lilly
LLY
+$197M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 18.6%
3 Financials 10.47%
4 Industrials 10.2%
5 Consumer Discretionary 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CFRX
2501
DELISTED
ContraFect Corporation
CFRX
$40K ﹤0.01%
164
-9
-5% -$2.54K
FRSX
2502
Foresight Autonomous Holdings
FRSX
$3.84M
$39K ﹤0.01%
494
-24
-5% -$2.37K
IRIX icon
2503
IRIDEX
IRIX
$15.5M
$39K ﹤0.01%
15,100
-2,500
-14% -$8.51K
VINC
2504
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$39K ﹤0.01%
1,475
+120
+9% +$5.34K
IVVD icon
2505
Invivyd
IVVD
$179M
$38K ﹤0.01%
+11,600
New +$36.4K
SPPI
2506
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$38K ﹤0.01%
48,300
-536,700
-92% -$473K
LSTA icon
2507
Lisata Therapeutics
LSTA
$13.2M
$36K ﹤0.01%
4,587
-4,586
-50% -$37.7K
ARTW icon
2508
Arts-Way Manufacturing Co
ARTW
$12.2M
$35K ﹤0.01%
+11,800
New +$35.3K
STRR
2509
DELISTED
Star Equity Holdings
STRR
$35K ﹤0.01%
7,500
-240
-3% -$1.15K
WINT
2510
DELISTED
Windtree Therapeutics
WINT
$35K ﹤0.01%
2
AGTC
2511
DELISTED
Applied Genetic Technologies Corporation
AGTC
$34K ﹤0.01%
44,049
-73,680
-63% -$65.7K
CO
2512
DELISTED
Global Cord Blood Corporation
CO
$34K ﹤0.01%
11,400
-100
-0.9% -$310
CGTX icon
2513
Cognition Therapeutics
CGTX
$84.1M
$33K ﹤0.01%
15,600
-12,500
-44% -$32.3K
JG
2514
Aurora Mobile
JG
$26.1M
$33K ﹤0.01%
1,535
-165
-10% -$3.35K
SDC
2515
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$32K ﹤0.01%
31,200
-24,800
-44% -$40.1K
AQST icon
2516
Aquestive Therapeutics
AQST
$468M
$31K ﹤0.01%
47,900
-4,500
-9% -$5.99K
VISL
2517
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$31K ﹤0.01%
2,620
-225
-8% -$3.39K
AWX icon
2518
Avalon Holdings
AWX
$10.1M
$30K ﹤0.01%
11,700
-2,900
-20% -$9.03K
BFRI icon
2519
Biofrontera
BFRI
$13.6M
$30K ﹤0.01%
810
-990
-55% -$60.1K
GTBP icon
2520
GT Biopharma
GTBP
$11.9M
$30K ﹤0.01%
340
-277
-45% -$21K
LVO icon
2521
LiveOne
LVO
$65.1M
$30K ﹤0.01%
3,470
-10
-0.3% -$82
SY
2522
So-Young International
SY
$197M
$30K ﹤0.01%
34,600
+15,200
+78% +$19.1K
ARDX icon
2523
Ardelyx
ARDX
$1.27B
$29K ﹤0.01%
48,900
-50,000
-51% -$36.8K
HYPD
2524
Hyperion DeFi Inc
HYPD
$38.5M
$29K ﹤0.01%
184
-47
-20% -$8.59K
TOVX icon
2525
Theriva Biologics
TOVX
$9.78M
$29K ﹤0.01%
541
-20
-4% -$1.15K

Similar funds

Two Sigma Advisers's Q2 2022 Portfolio in Review

As of Q2 2022, Two Sigma Advisers held 3,021 positions worth $35.3B, down 6.3% from $37.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Two Sigma Advisers deployed $5.08B of net new capital in Q2 2022, opening 306 new positions and adding to 1,176 existing holdings. Its largest new stake was Snap: 14,064,077 shares worth $185M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was AbbVie, an estimated $283M trimmed.

  • Two Sigma Advisers's largest Q2 2022 buy was Snap: 14,064,077 shares worth $185M.
  • Two Sigma Advisers added most to Netflix in Q2 2022, an estimated $410M increase.
  • Two Sigma Advisers's biggest Q2 2022 reduction was AbbVie, cutting an estimated $283M.
  • Two Sigma Advisers fully exited Cerner Corp in Q2 2022, selling an estimated $407M.
  • Two Sigma Advisers's ten largest holdings make up 13% of its $35.3B portfolio in Q2 2022.
  • Two Sigma Advisers opened 306 new positions and closed 398 in Q2 2022.
  • Two Sigma Advisers's portfolio value fell 6.3% quarter-over-quarter to $35.3B.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.